# Pertussis Vaccine in Healthy Pregnant Women

> **NCT00707148** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 80 (actual)

## Conditions studied

- Diphtheria
- Pertussis
- Tetanus

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed

## Key facts

- **NCT ID:** NCT00707148
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707148, "Pertussis Vaccine in Healthy Pregnant Women". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00707148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*